ENFit Syringes Market, By Syringe Size, By Tip Type, By Usage Type, By Material Type, By Distribution Channel, By Application, By Patient Group, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-203
Description
REPORT HIGHLIGHT
ENFit syringes market size was valued at US$ 798.10 Million in 2024, expanding at a CAGR of 6.77% from 2025 to 2032.
ENFit syringes are specialized enteral feeding syringes designed with standardized, non-Luer connectors to prevent misconnections between enteral, intravenous, and other medical delivery systems. These devices support safe administration of nutrition, hydration, and medications via feeding tubes across neonatal, pediatric, and adult care settings. Modern ENFit syringes emphasize patient safety, regulatory compliance, dosing accuracy, compatibility with enteral feeding systems, and ease of use. Market opportunities are driven by global patient safety standards, hospital safety protocols, rising enteral nutrition adoption, regulatory mandates for connector standardization, and growing awareness of medication error prevention in healthcare environments.
ENFit Syringes Market- Market Dynamics
Patient safety mandates, regulatory standardization, and misconnection prevention to propel market demand
Rising patient safety concerns are accelerating adoption of ENFit syringes to prevent enteral misconnections. A Joint Commission sentinel event alert reported over 100 tubing misconnection errors and 21 deaths linked to legacy connectors, highlighting the severity of the issue. Additionally, a review of published misconnection incidents found that 96 cases occurred between 2011 and 2023, with 4% resulting in death and 69% causing patient harm, underscoring the need for standardized enteral delivery systems. The global implementation of the ISO 80369-3 connector standard mandates healthcare facilities to transition to ENFit-compliant syringes, reinforcing regulatory-driven market growth. The U.S. Food and Drug Administration (FDA) has formally supported adoption of incompatible enteral connectors to reduce medication administration errors. Furthermore, the World Health Organization (WHO) identifies medication errors as a leading cause of avoidable harm in healthcare, strengthening institutional emphasis on safer delivery systems. Increasing hospital accreditation requirements and patient safety audits are also accelerating conversion from legacy enteral connectors to ENFit systems.
ENFit Syringes Market- Segmentation Analysis:
The Global ENFit Syringes Market is segmented on the basis of Syringe Size, Tip Type, Usage Type, Material Type, Distribution Channel, Application, Patient Group, End User, and Region.
Based on Syringe Size, the market is categorized into 0.5 mL–1 mL, 3 mL–5 mL, 6 mL–10 mL, 20 mL–35 mL, 60 mL and above, and Others. Smaller sizes, such as 0.5–1 mL and 3–5 mL, are predominantly used for precise delivery of medications and small-volume flushing in neonatal and pediatric enteral care. Mid-range volumes like 6–10 mL and 20–35 mL are commonly employed for routine enteral nutrition and medication administration in adult clinical settings, aligning with standard enteral feeding protocols detailed by the World Health Organization (WHO), which emphasizes accurate dosing as critical to patient safety. Larger syringes of 60 mL and above are typically used for high-volume flushing and nutrition bolus delivery, especially in long-term care facilities where batch feeding is practiced. The “Others” category accommodates specialized or non-standard sizes used in niche clinical settings.
Based on the application, the market is divided into Medication Delivery, Flushing, Nutrition Delivery, Sampling, and Others. Medication Delivery leverages ENFit syringes to ensure incompatibility with intravenous lines, directly supporting safety initiatives promoted by organizations like the U.S. Food and Drug Administration (FDA) to reduce enteral misconnections. Flushing applications involve clearing enteral feeding tubes to maintain patency and prevent blockages, a practice endorsed in clinical enteral feeding guidelines. Nutrition Delivery represents the administration of enteral nutrition formulas, a core use case aligned with hospital enteral nutrition protocols as referenced by national clinical nutrition associations. Sampling captures the withdrawal of gastric or intestinal contents for diagnostic assessment. The “Others” segment includes ancillary uses such as contrast agent delivery for imaging procedures or clinical research applications.
ENFit Syringes Market- Geographical Insights
The global ENFit syringes market exhibits notable regional variation influenced by the burden of noncommunicable diseases (which often require enteral nutrition support), healthcare infrastructure maturity, and regulatory emphasis on patient safety. According to the World Health Organization (WHO), noncommunicable diseases (NCDs) accounted for at least 75% of all non-pandemic deaths globally in 2021, highlighting the widespread demand for clinical nutrition and related enteral devices in diverse healthcare settings.
North America demonstrates strong market strength due to advanced clinical nutrition programs, extensive enteral feeding protocols, and well-established hospital infrastructures that support standardized enteral device adoption. Europe follows with significant adoption of safety-compliant enteral feeding systems supported by universal healthcare policies and comprehensive patient safety regulations. In Asia-Pacific, expanding healthcare access and rising chronic disease prevalence are driving demand for enteral syringes, while Latin America and the Middle East & Africa show steady growth as government-led healthcare improvements and nutrition support awareness expand. The regional market performance reflects differing healthcare system capacities, disease burdens, and policy emphases on safe medical device utilization across global regions.
U.S. ENFit Syringes Market-Country Insights
The United States leads the global ENFit syringes market, driven by advanced healthcare infrastructure, high awareness of patient safety, and widespread adoption of enteral feeding protocols. According to market data, the U.S. ENFit syringes segment recorded a market size of USD 226.09 million in 2025, reflecting its dominant position and early standard adoption. The U.S. healthcare system’s focus on safe medication and nutrition delivery, combined with proactive clinical guidelines supporting ENFit implementation, sustains high adoption rates across hospitals, long-term care facilities, and homecare services. These factors collectively reinforce the United States as the leading national market for ENFit syringes globally.
ENFit Syringes Market- Competitive Landscape:
The global ENFit syringes market is competitive and characterized by the presence of several established multinational medical device manufacturers alongside regional and specialized producers. Key players include Becton Dickinson and Company, Braun Melsungen, Baxter International, Cardinal Health, Avanos Medical, Medline Industries, Fresenius Kabi, and others. These players are contributing to market dynamics by expanding ENFit-compliant product portfolios and engaging in strategic partnerships or supply agreements. Market competition is driven by innovations in syringe design, customization for clinical needs, and enhanced safety features to support enteral feeding protocols compliant with ISO 80369-3 standards. Companies are increasingly focusing on broadening their geographic reach, strengthening distribution networks in hospitals and home healthcare channels, and investing in R&D to improve ergonomic and infection-control characteristics of ENFit syringes.
Recent Developments:
In January 2026, ENvue Medical launched a new line of over-the-counter reusable ENFit syringes for enteral feeding and medication delivery that meet ISO 80369-3 standards. Available in multiple sizes without a prescription, these syringes aim to improve safety and continuity of care for patients in clinical and home settings.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ENFIT SYRINGES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Becton Dickinson and Company
Braun Melsungen
Baxter International
Cardinal Health
Avanos Medical
Medline Industries
Fresenius Kabi
HMC Group
Vygon
Medicina
Vesco Medical
GBUK Group
Amsino International
KB Medical Group
Kentec Medical
Others
GLOBAL ENFIT SYRINGES MARKET, BY SYRINGE SIZE- MARKET ANALYSIS, 2019 - 2032
0.5 mL – 1 mL
3 mL – 5 mL
6 mL – 10 mL
20 mL – 35 mL
60 mL and above
Others
GLOBAL ENFIT SYRINGES MARKET, BY TIP TYPE- MARKET ANALYSIS, 2019 - 2032
Standard Tip ENFit Syringes
Low Dose Tip (LDT) ENFit Syringes
Others (e.g., catheter tip variants)
GLOBAL ENFIT SYRINGES MARKET, BY USAGE TYPE- MARKET ANALYSIS, 2019 - 2032
Reusable ENFit Syringes
Disposable ENFit Syringes
GLOBAL ENFIT SYRINGES MARKET, BY MATERIAL TYPE- MARKET ANALYSIS, 2019 - 2032
Polypropylene (PP)
Silicone
Polyethylene (PE)
Others (e.g., Glass, PVC-free polymers)
GLOBAL ENFIT SYRINGES MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Direct Tenders
Others
GLOBAL ENFIT SYRINGES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Medication Delivery
Flushing
Nutrition Delivery
Sampling
Others
GLOBAL ENFIT SYRINGES MARKET, BY PATIENT GROUP- MARKET ANALYSIS, 2019 - 2032
Geriatric
Adults
Neonates & Pediatric
GLOBAL ENFIT SYRINGES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
Hospitals
Long-Term Care Facilities
Home Healthcare Settings
Rehabilitation Centers
Clinics & Ambulatory Surgical Centers
Others
GLOBAL ENFIT SYRINGES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
ENFit syringes market size was valued at US$ 798.10 Million in 2024, expanding at a CAGR of 6.77% from 2025 to 2032.
ENFit syringes are specialized enteral feeding syringes designed with standardized, non-Luer connectors to prevent misconnections between enteral, intravenous, and other medical delivery systems. These devices support safe administration of nutrition, hydration, and medications via feeding tubes across neonatal, pediatric, and adult care settings. Modern ENFit syringes emphasize patient safety, regulatory compliance, dosing accuracy, compatibility with enteral feeding systems, and ease of use. Market opportunities are driven by global patient safety standards, hospital safety protocols, rising enteral nutrition adoption, regulatory mandates for connector standardization, and growing awareness of medication error prevention in healthcare environments.
ENFit Syringes Market- Market Dynamics
Patient safety mandates, regulatory standardization, and misconnection prevention to propel market demand
Rising patient safety concerns are accelerating adoption of ENFit syringes to prevent enteral misconnections. A Joint Commission sentinel event alert reported over 100 tubing misconnection errors and 21 deaths linked to legacy connectors, highlighting the severity of the issue. Additionally, a review of published misconnection incidents found that 96 cases occurred between 2011 and 2023, with 4% resulting in death and 69% causing patient harm, underscoring the need for standardized enteral delivery systems. The global implementation of the ISO 80369-3 connector standard mandates healthcare facilities to transition to ENFit-compliant syringes, reinforcing regulatory-driven market growth. The U.S. Food and Drug Administration (FDA) has formally supported adoption of incompatible enteral connectors to reduce medication administration errors. Furthermore, the World Health Organization (WHO) identifies medication errors as a leading cause of avoidable harm in healthcare, strengthening institutional emphasis on safer delivery systems. Increasing hospital accreditation requirements and patient safety audits are also accelerating conversion from legacy enteral connectors to ENFit systems.
ENFit Syringes Market- Segmentation Analysis:
The Global ENFit Syringes Market is segmented on the basis of Syringe Size, Tip Type, Usage Type, Material Type, Distribution Channel, Application, Patient Group, End User, and Region.
Based on Syringe Size, the market is categorized into 0.5 mL–1 mL, 3 mL–5 mL, 6 mL–10 mL, 20 mL–35 mL, 60 mL and above, and Others. Smaller sizes, such as 0.5–1 mL and 3–5 mL, are predominantly used for precise delivery of medications and small-volume flushing in neonatal and pediatric enteral care. Mid-range volumes like 6–10 mL and 20–35 mL are commonly employed for routine enteral nutrition and medication administration in adult clinical settings, aligning with standard enteral feeding protocols detailed by the World Health Organization (WHO), which emphasizes accurate dosing as critical to patient safety. Larger syringes of 60 mL and above are typically used for high-volume flushing and nutrition bolus delivery, especially in long-term care facilities where batch feeding is practiced. The “Others” category accommodates specialized or non-standard sizes used in niche clinical settings.
Based on the application, the market is divided into Medication Delivery, Flushing, Nutrition Delivery, Sampling, and Others. Medication Delivery leverages ENFit syringes to ensure incompatibility with intravenous lines, directly supporting safety initiatives promoted by organizations like the U.S. Food and Drug Administration (FDA) to reduce enteral misconnections. Flushing applications involve clearing enteral feeding tubes to maintain patency and prevent blockages, a practice endorsed in clinical enteral feeding guidelines. Nutrition Delivery represents the administration of enteral nutrition formulas, a core use case aligned with hospital enteral nutrition protocols as referenced by national clinical nutrition associations. Sampling captures the withdrawal of gastric or intestinal contents for diagnostic assessment. The “Others” segment includes ancillary uses such as contrast agent delivery for imaging procedures or clinical research applications.
ENFit Syringes Market- Geographical Insights
The global ENFit syringes market exhibits notable regional variation influenced by the burden of noncommunicable diseases (which often require enteral nutrition support), healthcare infrastructure maturity, and regulatory emphasis on patient safety. According to the World Health Organization (WHO), noncommunicable diseases (NCDs) accounted for at least 75% of all non-pandemic deaths globally in 2021, highlighting the widespread demand for clinical nutrition and related enteral devices in diverse healthcare settings.
North America demonstrates strong market strength due to advanced clinical nutrition programs, extensive enteral feeding protocols, and well-established hospital infrastructures that support standardized enteral device adoption. Europe follows with significant adoption of safety-compliant enteral feeding systems supported by universal healthcare policies and comprehensive patient safety regulations. In Asia-Pacific, expanding healthcare access and rising chronic disease prevalence are driving demand for enteral syringes, while Latin America and the Middle East & Africa show steady growth as government-led healthcare improvements and nutrition support awareness expand. The regional market performance reflects differing healthcare system capacities, disease burdens, and policy emphases on safe medical device utilization across global regions.
U.S. ENFit Syringes Market-Country Insights
The United States leads the global ENFit syringes market, driven by advanced healthcare infrastructure, high awareness of patient safety, and widespread adoption of enteral feeding protocols. According to market data, the U.S. ENFit syringes segment recorded a market size of USD 226.09 million in 2025, reflecting its dominant position and early standard adoption. The U.S. healthcare system’s focus on safe medication and nutrition delivery, combined with proactive clinical guidelines supporting ENFit implementation, sustains high adoption rates across hospitals, long-term care facilities, and homecare services. These factors collectively reinforce the United States as the leading national market for ENFit syringes globally.
ENFit Syringes Market- Competitive Landscape:
The global ENFit syringes market is competitive and characterized by the presence of several established multinational medical device manufacturers alongside regional and specialized producers. Key players include Becton Dickinson and Company, Braun Melsungen, Baxter International, Cardinal Health, Avanos Medical, Medline Industries, Fresenius Kabi, and others. These players are contributing to market dynamics by expanding ENFit-compliant product portfolios and engaging in strategic partnerships or supply agreements. Market competition is driven by innovations in syringe design, customization for clinical needs, and enhanced safety features to support enteral feeding protocols compliant with ISO 80369-3 standards. Companies are increasingly focusing on broadening their geographic reach, strengthening distribution networks in hospitals and home healthcare channels, and investing in R&D to improve ergonomic and infection-control characteristics of ENFit syringes.
Recent Developments:
In January 2026, ENvue Medical launched a new line of over-the-counter reusable ENFit syringes for enteral feeding and medication delivery that meet ISO 80369-3 standards. Available in multiple sizes without a prescription, these syringes aim to improve safety and continuity of care for patients in clinical and home settings.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ENFIT SYRINGES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Becton Dickinson and Company
Braun Melsungen
Baxter International
Cardinal Health
Avanos Medical
Medline Industries
Fresenius Kabi
HMC Group
Vygon
Medicina
Vesco Medical
GBUK Group
Amsino International
KB Medical Group
Kentec Medical
Others
GLOBAL ENFIT SYRINGES MARKET, BY SYRINGE SIZE- MARKET ANALYSIS, 2019 - 2032
0.5 mL – 1 mL
3 mL – 5 mL
6 mL – 10 mL
20 mL – 35 mL
60 mL and above
Others
GLOBAL ENFIT SYRINGES MARKET, BY TIP TYPE- MARKET ANALYSIS, 2019 - 2032
Standard Tip ENFit Syringes
Low Dose Tip (LDT) ENFit Syringes
Others (e.g., catheter tip variants)
GLOBAL ENFIT SYRINGES MARKET, BY USAGE TYPE- MARKET ANALYSIS, 2019 - 2032
Reusable ENFit Syringes
Disposable ENFit Syringes
GLOBAL ENFIT SYRINGES MARKET, BY MATERIAL TYPE- MARKET ANALYSIS, 2019 - 2032
Polypropylene (PP)
Silicone
Polyethylene (PE)
Others (e.g., Glass, PVC-free polymers)
GLOBAL ENFIT SYRINGES MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Direct Tenders
Others
GLOBAL ENFIT SYRINGES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Medication Delivery
Flushing
Nutrition Delivery
Sampling
Others
GLOBAL ENFIT SYRINGES MARKET, BY PATIENT GROUP- MARKET ANALYSIS, 2019 - 2032
Geriatric
Adults
Neonates & Pediatric
GLOBAL ENFIT SYRINGES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
Hospitals
Long-Term Care Facilities
Home Healthcare Settings
Rehabilitation Centers
Clinics & Ambulatory Surgical Centers
Others
GLOBAL ENFIT SYRINGES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
Table of Contents
341 Pages
- 1. ENFit Syringes Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
- 2. Executive Summary
- 2.1. Market Snippet
- 2.2. Competitive Insights
- 3. ENFit Syringes Key Market Trends
- 3.1. ENFit Syringes Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. ENFit Syringes Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. ENFit Syringes Market Opportunities
- 3.4. ENFit Syringes Market Future Trends
- 4. ENFit Syringes Industry Study
- 4.1. PEST Analysis
- 4.2. Porter’s Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
- 5. ENFit Syringes Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
- 6. ENFit Syringes Market Landscape
- 6.1. ENFit Syringes Market Share Analysis, 2024
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players’ Analysis
- 6.2.2. Emerging Players’ Analysis
- 7. ENFit Syringes Market – By Syringe Size
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Syringe Size, 2024 & 2032 (%)
- 7.1.1.1. 0.5 mL – 1 mL
- 7.1.1.2. 3 mL – 5 mL
- 7.1.1.3. 6 mL – 10 mL
- 7.1.1.4. 20 mL – 35 mL
- 7.1.1.5. 60 mL and above
- 7.1.1.6. Others
- 8. ENFit Syringes Market – By Tip Type
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Tip Type, 2024 & 2032 (%)
- 8.1.2. Standard Tip ENFit Syringes
- 8.1.3. Low Dose Tip (LDT) ENFit Syringes
- 8.1.4. Others (e.g., catheter tip variants)
- 9. ENFit Syringes Market – By Usage Type
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Usage Type, 2024 & 2032 (%)
- 9.1.2. Reusable ENFit Syringes
- 9.1.3. Disposable ENFit Syringes
- 10. ENFit Syringes Market – By Material Type
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Material Type, 2024 & 2032 (%)
- 10.1.2. Polypropylene (PP)
- 10.1.3. Silicone
- 10.1.4. Polyethylene (PE)
- 10.1.5. Others (e.g., Glass, PVC-free polymers)
- 11. ENFit Syringes Market – By Distribution Channel
- 11.1. Overview
- 11.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
- 11.1.2. Hospital Pharmacies
- 11.1.3. Online Pharmacies
- 11.1.4. Retail Pharmacies
- 11.1.5. Direct Tenders
- 11.1.6. Others
- 12. ENFit Syringes Market – By Application
- 12.1. Overview
- 12.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 12.1.2. Medication Delivery
- 12.1.3. Flushing
- 12.1.4. Nutrition Delivery
- 12.1.5. Sampling
- 12.1.6. Others
- 13. ENFit Syringes Market – By Patient Group
- 13.1. Overview
- 13.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 13.1.2. Geriatric
- 13.1.3. Adults
- 13.1.4. Neonates & Pediatric
- 14. ENFit Syringes Market – By End User
- 14.1. Overview
- 14.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 14.1.2. Hospitals
- 14.1.3. Long-Term Care Facilities
- 14.1.4. Home Healthcare Settings
- 14.1.5. Rehabilitation Centers
- 14.1.6. Clinics & Ambulatory Surgical Centers
- 14.1.7. Others
- 15. ENFit Syringes Market– By Geography
- 15.1. Introduction
- 15.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
- 15.2. North America
- 15.2.1. Overview
- 15.2.2. ENFit Syringes Key Manufacturers in North America
- 15.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 15.2.4. North America Market Size and Forecast, By Syringe Size, 2019 - 2032 (US$ Million)
- 15.2.5. North America Market Size and Forecast, By Tip Type, 2019 - 2032 (US$ Million)
- 15.2.6. North America Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
- 15.2.7. North America Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
- 15.2.8. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 15.2.9. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 15.2.10. North America Market Size and Forecast, By Patient Group, 2019 - 2032 (US$ Million)
- 15.2.11. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 15.2.12. U.S.
- 15.2.13. Canada
- 15.3. Europe
- 15.3.1. Overview
- 15.3.2. ENFit Syringes Key Manufacturers in Europe
- 15.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 15.3.4. Europe Market Size and Forecast, By Syringe Size, 2019 - 2032 (US$ Million)
- 15.3.5. Europe Market Size and Forecast, By Tip Type, 2019 - 2032 (US$ Million)
- 15.3.6. Europe Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
- 15.3.7. Europe Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
- 15.3.8. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 15.3.9. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 15.3.10. Europe Market Size and Forecast, By Patient Group, 2019 - 2032 (US$ Million)
- 15.3.11. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 15.3.12. Germany
- 15.3.13. UK
- 15.3.14. France
- 15.3.15. Italy
- 15.3.16. Spain
- 15.3.17. The Netherlands
- 15.3.18. Sweden
- 15.3.19. Russia
- 15.3.20. Poland
- 15.3.21. Rest of Europe
- 15.4. Asia Pacific (APAC)
- 15.4.1. Overview
- 15.4.2. ENFit Syringes Key Manufacturers in Asia Pacific
- 15.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 15.4.4. Asia Pacific Market Size and Forecast, By Syringe Size, 2019 - 2032 (US$ Million)
- 15.4.5. Asia Pacific Market Size and Forecast, By Tip Type, 2019 - 2032 (US$ Million)
- 15.4.6. Asia Pacific Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
- 15.4.7. Asia Pacific Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
- 15.4.8. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 15.4.9. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 15.4.10. Asia Pacific Market Size and Forecast, By Patient Group, 2019 - 2032 (US$ Million)
- 15.4.11. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 15.4.12. China
- 15.4.13. India
- 15.4.14. Japan
- 15.4.15. South Korea
- 15.4.16. Australia
- 15.4.17. Indonesia
- 15.4.18. Thailand
- 15.4.19. Philippines
- 15.4.20. Rest of Asia Pacific
- 15.5. Latin America
- 15.5.1. Overview
- 15.5.2. ENFit Syringes Key Manufacturers in Latin America
- 15.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 15.5.4. Latin America Market Size and Forecast, By Syringe Size, 2019 - 2032 (US$ Million)
- 15.5.5. Latin America Market Size and Forecast, By Tip Type, 2019 - 2032 (US$ Million)
- 15.5.6. Latin America Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
- 15.5.7. Latin America Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
- 15.5.8. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 15.5.9. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 15.5.10. Latin America Market Size and Forecast, By Patient Group, 2019 - 2032 (US$ Million)
- 15.5.11. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 15.5.12. Brazil
- 15.5.13. Mexico
- 15.5.14. Argentina
- 15.5.15. Columbia
- 15.5.16. Rest of Latin America
- 15.6. Middle East and Africa
- 15.6.1. Overview
- 15.6.2. ENFit Syringes Key Manufacturers in Middle East and Africa
- 15.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 15.6.4. Middle East and Africa Market Size and Forecast, By Syringe Size, 2019 - 2032 (US$ Million)
- 15.6.5. Middle East and Africa Market Size and Forecast, By Tip Type, 2019 - 2032 (US$ Million)
- 15.6.6. Middle East and Africa Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
- 15.6.7. Middle East and Africa Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
- 15.6.8. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
- 15.6.9. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 15.6.10. Middle East and Africa Market Size and Forecast, By Patient Group, 2019 - 2032 (US$ Million)
- 15.6.11. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 15.6.12. Saudi Arabia
- 15.6.13. UAE
- 15.6.14. Israel
- 15.6.15. Turkey
- 15.6.16. Algeria
- 15.6.17. Egypt
- 15.6.18. Rest of Middle East and Africa
- 16. Key Vendor Analysis- ENFit Syringes Industry
- 16.1. Competitive Dashboard
- 16.1.1. Competitive Benchmarking
- 16.1.2. Competitive Positioning
- 16.2. Company Profiles
- 16.2.1. Becton Dickinson and Company
- 16.2.2. Braun Melsungen
- 16.2.3. Baxter International
- 16.2.4. Cardinal Health
- 16.2.5. Avanos Medical
- 16.2.6. Medline Industries
- 16.2.7. Fresenius Kabi
- 16.2.8. HMC Group
- 16.2.9. Vygon
- 16.2.10. Medicina
- 16.2.11. Vesco Medical
- 16.2.12. GBUK Group
- 16.2.13. Amsino International
- 16.2.14. KB Medical Group
- 16.2.15. Kentec Medical
- 16.2.16. Others
- 17. 360 Degree Analyst View
- 18. Appendix
- 18.1. Research Methodology
- 18.2. References
- 18.3. Abbreviations
- 18.4. Disclaimer
- 18.5. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
